AB75. Lower urinary tract dysfunction in a pink1 gene knockout rat model for Parkinson’s disease
Prospective Study on Neuroinflammation, published in Transl Androl Urol (2014) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Prospective Study
- Journal
- Transl Androl Urol (2014)
- Reported sample size
- —
- Source database
- Europe PMC
- PMCID
- PMC4708500
Abstract (original English)
Bladder dysfunction is a common non-motor disorder on Parkinson’s disease (PD) patients. A new transgenic Pink1 gene knockout rat model of PD has been developed recently. To explore lower urinary tract function in this newly established PD model and provide possible therapeutic base for PD urinary complications. Twelve Pink1 KO rats (pink1-/-, LEH-pink1tm 1sage, 40 weeks old) and twelve wide type rats (pink1+/+, LEH, 40 weeks old) were used in this project. After acclimation, the rats underwent 24 hours metabolic cage test, conscious cystometry, and leak point pressure test. Their bladders were harvested, weighted and then fixed for histological study. Total volume, micturition times, and voided volume per micturition were calculated for 24h metabolic cage test. Pressure parameters, micturition frequency, bladder capacity/compliance, volume parameters, leak point pressure (LPP) were analyzed according to the result of cystometry and LPP test. Body weight, bladder weight, and the general pathologic changes in bladder were also checked. Continuous variables were compared between groups using t-test. Categorical variables were compared using Chi-square test. P<0.05 was set as statistical significant. Pink1 KO rats acquired the functional disorder of detrusor over activity compared to wild type rats. Hyperplasia of smooth muscle and nerves were noted in the bladder wall of Pink1 KO
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Adipose-Derived Stem Cells in Traumatic Brain Injury: A Systematic Review of Preclinical Studies.
Systematic Review on Neuroinflammation, published in Tissue Eng Regen Med (2026) — summary generated from the PubMed abstract.
- 2026
Tissue Eng Regen Med - Level ASystematic ReviewPubMed
The use of cellular therapies for trigeminal neuralgia: a systematic review of behavioral and molecular outcomes.
Systematic Review with a reported sample of 8 on Neuroinflammation, published in Neurosurg Rev (2026) — summary generated from the PubMed abstract.
- 2026
- n = 8
Neurosurg Rev - Level ASystematic ReviewEurope PMC
Factor XII-A New Therapeutic Target? A Systematic Review
Systematic Review on Cardiovascular Disease, Neuroinflammation, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci1 citations - Level ASystematic ReviewEurope PMC
Efficacy of Exosome-Based Therapies for Skin Rejuvenation: A Systematic Review of Human Studies
Systematic Review on Neuroinflammation, Skin Aging, published in Cureus (2026) — summary generated from the PubMed abstract.
- 2026
Cureus - Level ASystematic ReviewEurope PMC
Harnessing exosomes in dry eye disease: a triple threat approach
Systematic Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in BMC Ophthalmol (2026) — summary generated from the PubMed abstract.
- 2026
BMC Ophthalmol - Level ASystematic ReviewEurope PMC
Safety and Efficacy of Mesenchymal Stem Cell Therapy in Multiple System Atrophy: Systematic Review
Systematic Review with a reported sample of 123 on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in Biologics (2026) — summary generated from the PubMed abstract.
- 2026
- n = 123
Biologics